Dear editor, Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly without a cure. 1 Although the amyloid cascade hypothesis is the mainstream theory of AD pathogenesis for decades, it has been challenged due to unsatisfied outcomes of clinical trials that aim to mitigate the amyloid plaque burden. Emerging evidence has suggested that excessive generation of reactive oxygen species (ROS) including superoxide anion, hydroxyl radical, and H 2 O 2 is a key process to induce neuroinflammation and neuronal loss in AD, implicating ROS as a promising target for AD therapy. 1 Generally, there are two common types of ROS scavengers, natural enzymes and antioxidant drugs. 2,3 However, they have not been applied for AD therapeutics yet due to high cost, low stability, difficulty of recycling, and limited scavenging capacity for multiple types of ROS. Inspiringly, nanozymes, the nanomaterials for mimicking the catalytic properties of natural enzymes, have emerged as excellent substitutes for ROS natural scavengers as they are more stable, durable, and cost-friendly than natural enzymes and antioxidant drugs. 2,3 Nanozymes therefore have been reported to facilitate the technological innovations of biomedicine, including the development of nanomaterials with multi-biofunctions for tissue engineering, neurodegenerative diseases, cancer therapy, and disease diagnosis. 4 Nanozymes can be further decorated/modified with polymer, protein, or cell membrane to protect their catalytic activities and improve their stability and biocompatibility for biological applications. 3 Recently, we reported the synthesis of an ultrasmall insulin-incubated palladium nanozyme Pd@insulin (Pd-In), via a novel biomimetic synthesis method. 2 This method utilizes the spatial confinement effect and protein-mediated biomimetic biomineralization, which is convenient, green, and highly effective. Pd-based nanozyme was chosen due to its specific electronic structure that mimics the catalytic properties of natural enzymes. 2 Pd-based nanozymes has been shown to mimicThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.